Detection And Prevention
Patients have the best chance for successful treatment when breast cancer is found early. All women with average risk should have a mammogram every year, beginning at age 40. A physician order is not needed for women 40 and older.
Premier Health Mammography Procedures
Mammography is an important tool in detecting breast cancer early. The diagram below, which was designed to help determine the most accurate and least invasive means for clinical evaluation of the breasts, will expedite patient care and reduce calls to the physician office.
Screening Mammogram Algorithm
This screening mammogram algorithm outlines pathways for treatment based on the results of your patient’s mammogram.
Screening Mammography At Premier Health
All Premier Health breast imaging centers, as well as our mobile mammography coach offer screening mammography using either traditional two-dimensional mammography or the newer three-dimensional Genius™ 3D MAMMOGRAPHY™,
also known as tomosynthesis.
Breast cancer is the second most common form of cancer in women, according to the Centers for Disease Control and Prevention. Early detection increases the likelihood of successful treatment. Mammography remains the most common screening test for breast cancer.
Screening mammograms are for women who have no breast problems or complaints. Screening mammograms do not require a physician’s order or prescription for women age 40 and over.
Learn more if your mammography report shows you have dense breasts.
Fast Breast MRI
Premier Health offers Fast Breast MRI, a 10-minute self-pay examination. Women with dense breasts or at a higher risk for breast cancer can now choose Fast Breast MRI at Premier Health as a second step (following a mammogram) for breast cancer screening. It’s important to note that Fast Breast MRI isn’t a replacement for an annual mammogram.
BRCA-Related Cancer
Premier Health offers these recommendations for women with and without a personal or family history of cancers associated with the BRCA 1/2 gene mutation.
Population | Recommendation |
Women with a personal or family history of breast, ovarian, tubal, or peritoneal cancer or an ancestry associated with BRCA1/2 gene mutation. | The USPSTF recommends that primary care clinicians assess women with a personal or family history of breast, ovarian, tubal, or peritoneal cancer or who have an ancestry associated with breast cancer susceptibility 1 and 2 (BRCA1/2) gene mutations with an appropriate brief familial risk assessment tool. Women with a positive result on the risk assessment tool should receive genetic counseling and, if indicated after counseling, genetic testing. |
Women whose personal or family history or ancestry is not associated with potential harmful BRCA1/2 gene mutations. |
The USPSTF recommends against routine risk assessment, genetic counseling, or genetic testing for women whose personal or family history or ancestry is not associated with potentially harmful BRCA1/2 gene mutations. |
High-Risk Breast Cancer Centers
We offer this information for your patients:
If you are considered high-risk due to personal or family history, Premier Health’s High-Risk Breast Cancer Centers are dedicated to providing a comprehensive breast cancer risk evaluation, follow-up care, and education. High-risk Breast Cancer Centers are located at Miami Valley Hospital North and Miami Valley Hospital South.
Genetic Testing And Counseling
We offer this information for your patients:
If you are at increased risk for breast cancer, our genetic counselors at our High-risk Breast Cancer Centers can provide information, address your concerns, and offer testing when appropriate.
Contact Us
Premier Health offers an extensive network of experienced cancer specialists, close to home, who welcome your referrals. Find a cancer specialist best suited to your patient’s unique needs.
Our cancer specialists have access to nationally recognized cancer care protocols and best practices, since Premier Health is a certified member of MD Anderson Cancer Network®, a program of MD Anderson Cancer Center.